We further investigated the clinical role of PES1 in HNSCC by determining whether PES1 alters HNSCC sensitivity to cisplatin, the most common chemotherapeutic drug for HNSCC.19 This evidence concerns the gene PES1 and head and neck squamous cell carcinoma.